LabConnect Partners with Kits4Life to Reduce Kit Waste and Advance Sustainable Clinical Trials
Clinical trials are essential to developing life-changing therapies, but they can also generate significant material waste—particularly unused and expired specimen collection kits. These kits often contain high-quality medical materials that, when responsibly redirected, can have a second life in communities with critical healthcare needs. 'We are excited to partner with Kits4Life as a framework for recovering surplus clinical trial kits and ensuring they are ethically and safely donated to organizations,' states Julia Tarasenko, Chief Commercial & Strategy Officer at LabConnect.
LabConnect's ESG strategy focuses on transforming clinical trials into a more sustainable and inclusive global enterprise. From carbon footprint reduction to ethical sourcing and community engagement, we are integrating environmental and social responsibility across the full lifecycle of clinical research. Our work with Kits4Life is one more way we are turning strategy into action—by diverting valuable materials from waste streams and redirecting them to improve lives.
'We believe that sustainability and scientific innovation are not mutually exclusive—they are mutually reinforcing. As the clinical research industry evolves, partnerships like this help chart a path forward where environmental responsibility and breakthrough therapies go hand in hand,' adds Tarasenko.
About LabConnect
LabConnect is the leading provider of Central Laboratory Services, FSP and Scientific Consulting, and Data Integration and Transformation Services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare & orphan diseases.
LabConnect's unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs.
Learn more at www.labconnect.com and follow on LinkedIn.
View original content to download multimedia: https://www.prnewswire.com/news-releases/labconnect-partners-with-kits4life-to-reduce-kit-waste-and-advance-sustainable-clinical-trials-302524551.html
SOURCE LabConnect
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
12 minutes ago
- Forbes
In Photos: August's Full Sturgeon Moon Rises In Rare Double Display
The second full moon of summer in the Northern Hemisphere — the sturgeon moon — performed a rare trick of rising into twilight skies twice in successive nights this weekend. It appeared in the southeast just as Saturn was rising alongside it in the east, and traced a low arc across the southern sky as seen from the Northern Hemisphere. Here are all the best photos from around the world. A 98 percent illuminated waxing gibbous moon rises behind the Statue of Liberty, a day before the full Sturgeon Moon in New York City on August 7, 2025, as seen from Jersey City, New Jersey. (Photo by) Getty Images On Friday, Aug. 8, the full sturgeon moon appeared on the southeast horizon during dusk, just minutes after sunset, glowing a pale orange in the gathering dusk. It turned 100% full at 3:56 a.m. EDT on Saturday, Aug. 9, and was seen once again appearing on the horizon just after sunset, this time a little brighter orange. As seen from mid-northern latitudes, the sturgeon moon was seen rising in the southeast, tracing a low arc across the southern sky, and setting in the southwest around sunrise. On both nights, the full moon appeared just as Saturn was rising due east. It's relatively rare for a full moon to rise on successive nights just 30 minutes or so apart, as happened on Friday and Saturday. Although the moon rises, on average, 50 minutes later each night, when the angle of its orbital path is shallow — as it is right now, as seen from mid-latitudes of the Northern Hemisphere — the moon rises only slightly later each night. The full moon is seen rising behind the Libeskind tower (L) designed by Polish-born US architect Daniel Libeskind and and Isozaki tower designed by Japanese architect Arata Isozaki at the Citylife district in Milan, on August 8, 2025. (Photo by Stefano RELLANDINI / AFP) (Photo by STEFANO RELLANDINI/AFP via Getty Images) AFP via Getty Images According to Farmer's Almanac, August's moon gets its odd name from the abundant freshwater fishing in parts of North America in August, particularly of lake sturgeon in late summer. Other names — which make more sense to parts of the country and the world that don't have sturgeon fish — include harvest moon, moon of the ripening, grain moon, green corn moon, black cherries moon and plum moon. Sturgeon full moon rising behind Rocca Calascio castle is seen in Rocca Calascio, Italy, on August 8th, 2025. The Full Sturgeon Moon is a traditional name given to the full moon in August by Native American tribes because sturgeon fishes were most readily caught during this month in the Great Lakes of North America (Photo by Lorenzo Di Cola/NurPhoto via Getty Images) NurPhoto via Getty Images When the full moon is highest in the sky, it's such a bright, white color that it's difficult to look at. Only when it's relatively low down is it comfortable to view. When it's close to the horizon — at moonrise and moonset — it glows orange. That's because, as when viewing a sunset or a sunrise, your eyes are receiving light that has been filtered by Earth's atmosphere, which is thickest close to the horizon. It filters out short-wavelength blue light and more easily allows longer-wavelength reddish light through. People looking at full moon rising are seen in Rocca Calascio, Italy, on August 8th, 2025. The Full Sturgeon Moon is a traditional name given to the full moon in August by Native American tribes because sturgeon fishes were most readily caught during this month in the Great Lakes of North America (Photo by Lorenzo Di Cola/NurPhoto via Getty Images) NurPhoto via Getty Images Sturgeon Moon And The Perseid Meteor Shower Although the rise and set of the Sturgeon Moon was dramatic, it comes at a cost this month. One of the most prolific meteor showers of the year, the Perseids, peaks overnight on Aug. 12-13, when about 75 'shooting stars' can be seen each hour. However, the presence of a still bright waning full moon will make the faintest meteors impossible to see. Sturgeon full moon rising behind Santa Maria della Pietà Church is seen in Rocca Calascio, Italy, on August 8th, 2025. The Full Sturgeon Moon is a traditional name given to the full moon in August by Native American tribes because sturgeon fishes were most readily caught during this month in the Great Lakes of North America (Photo by Lorenzo Di Cola/NurPhoto via Getty Images) NurPhoto via Getty Images Next month, on Sept. 21, Saturn will be at opposition. All this means is that Earth — which orbits the sun a lot faster than Saturn — will be between Saturn and the sun. Consequently, Saturn will appear to rise at sunset and set at sunrise and be 100% illuminated from Earth's point of view. It will also be at its biggest and brightest of the year. The Sturgeon Moon rises through clouds over 42nd Street in New York City on August 8, 2025, as seen from Weehawken, New Jersey. (Photo by) Getty Images When Is The Next Full Moon? The September 2025 full moon is the corn moon, which will turn full on Sunday, Sept. 8. From Asia, Australia and the Pacific Ocean, it will be a total lunar eclipse, during which the moon will turn a reddish color for 82 minutes. It will be similar to that seen in North America on March 13-14, but September's total lunar eclipse will not be visible from North America. Further Reading Forbes See The Perseid Meteor Shower Now Before It Peaks, Experts Say By Jamie Carter Forbes Full Moon August 2025: When To See The 'Sturgeon Moon' Rise By Jamie Carter Forbes When And Where To See August's Stargazing Highlight On Monday By Jamie Carter
Yahoo
16 minutes ago
- Yahoo
Colorectal cancer diagnoses soar among younger adults for one key reason
Updated cancer screening guidance has reportedly caused a spike in diagnoses among younger Americans. According to two studies by the American Cancer Society (ACS), there's been a recent surge in colorectal cancer in people aged 45 to 49. ACS scientists found that after 15 years of stable colorectal cancer (CRC) trends, U.S. diagnoses of local-stage disease skyrocketed in this age group from 2019 to 2022 — including a 50% relative increase from 2021 to 2022. Prostate Cancer Screening After 70: Experts Question Guidance After Biden's Diagnosis "It is promising news, because the uptick in cases is likely due to first-time screening in the wake of new recommendations for younger, average-risk adults to begin testing for colorectal cancer earlier," lead author Elizabeth Schafer, an associate scientist and cancer researcher at ACS, commented in a press release. In 2018, ACS lowered the recommended age for CRC screenings from 50 to 45. The United States Preventive Services Task Force (USPSTF) enforced the same guidance in 2021. Read On The Fox News App In the first study, published in the Journal of the American Medical Association (JAMA), the researchers analyzed CRC diagnoses from 2004 to 2022 among adults aged 20 to 54, sorted by age, location and stage at diagnosis. 'Western Diet' Blamed For Growing Risk Of Gi Cancers Among Young Adults Diagnoses have increased by 1.6% each year since 2004 in the 20 to 39 age group, and by more than 2% annually since 2012 in those aged 40 to 44 and 50 to 54. A 1.1% annual increase in people 45 to 49 years old accelerated to 12% per year from 2019 to 2022. The ACS confirmed the increase was driven by the detection of local-stage tumors, which increased by nearly 19% each year for colon cancer and more than 25% for rectal cancer in that timeframe. Before this period, colon cancer detection rates had been stable, and rectal cancer detection rates had been declining. Rare Cancer Diagnoses Surge Dramatically Among Millennials And Gen X Advanced-stage disease also continues to steeply increase, ACS reported, rising from 1.7% to 2.9% annually since 2004 among adults under 45 and "even more rapidly" in the past 10 years in those aged 45 to 54. These findings led to another ACS study, also published in JAMA, which found that CRC screening among U.S. adults between 45 and 49 increased by 62% from 2019 to 2023. The scientists analyzed the data of more than 50,000 individuals to compare changes in screening. They found that CRC screening, which was at 20% in 2021, jumped to 37% in 2023. Among 45- to 49-year-olds, colonoscopy screening increased by 43%, and stool-based testing increased more than five times from 2019 to 2023. Lead author Jessica Star, associate scientist at ACS in Atlanta, considers it "thrilling" to see this increase in screening among younger individuals, as it's likely linked to earlier-stage diagnoses. "However, we still have a long way to go," she said in the release. "Screening for colorectal cancer in ages 45 to 49 remains suboptimal, and has not increased equitably by both educational attainment and insurance status." Paul E. Oberstein, M.D., medical oncologist and assistant director of the Pancreatic Cancer Center at NYU Langone Perlmutter Cancer Center, said the increase in screening is "successful in detecting more cancers at an early stage where the chance of cure is very high." Click Here To Sign Up For Our Health Newsletter "This ultimately should mean that fewer people are diagnosed later in life and fewer people have advanced colon cancer," Oberstein, who was not involved in the study, told Fox News Digital. "This study reinforces the need to focus research on understanding the causes of colon cancer increases – and possible steps to reduce these cases." The rate of colon cancer in those under 45 remains "substantially lower," he noted, "so it is not clear yet if universal screening at a younger age is beneficial." Some specific patients who are younger than 45 may benefit from earlier screening, however, such as those with a family history or personal risk factors, the oncologist added. Exercise Program Reduces Common Cancer Recurrence And Boosts Survival As colon cancer continues to increase in younger individuals, Oberstein recommends contacting a doctor if any concerning symptoms are noticed. Dr. Craig Eagle, chief medical officer of Guardant Health in California, added that early detection is "crucial," noting that the five-year survival rate for CRC is over 90% when the disease is caught in early stages. For more Health articles, visit "[This] plummets to 13% in late stages when symptoms usually appear," Eagle, who also was not involved in the research, told Fox News Digital. "The rise in diagnoses for those in their 40s is an alarming reminder that screening must be easier and more accessible to reach the 50 million Americans who remain unscreened."Original article source: Colorectal cancer diagnoses soar among younger adults for one key reason Solve the daily Crossword
Yahoo
41 minutes ago
- Yahoo
Brain tumour survivor feared the worst after starting to feel ill again, but a miracle had happened
In October 2003, 23-year-old Alexe Cherrington from Carmarthenshire was diagnosed with a brain tumour after collapsing at work. She was informed that without immediate surgery, she had only days to live. To make tragic news even worse, she was told that, even if she survived, her chances of ever being able to have children were extremely slim. Having recently started working in a hair salon, Alexe began experiencing unexplained blackouts and loss of consciousness. Her new GP attributed these episodes to stress and prescribed painkillers. However, as her symptoms worsened, Alexe's worried mother brought her home and took her to their family doctor. The doctor immediately advised Alexe to go straight to Morriston General Hospital in Swansea, where an MRI scan revealed a mass on her brain. Stay informed on Carms news by signing up to our newsletter here. READ MORE: Storm Dexter to hit UK within hours but Met Office says it's great news for heatwave READ MORE: Major Cardiff road closed as firefighters battle blaze 'The doctor said I had just days to live unless I had immediate surgery," Aleze said. "I was also told that I was unlikely to become pregnant due to the radiotherapy treatment I would need. I was numb, just shocked and horrified. I didn't have many choices. "Thinking back to that time, it's still all a blur. It was meant to be the start of me becoming independent and everything just fell apart. Mum burst into tears as doctors explained the risks: the tumour was dangerously large and pressing on vital parts of my brain. The doctors told me there was an 80% chance I would not survive an operation and a 20% chance of severe disability if I did. I was numb.' Initially planned to be minimally invasive, surgeons soon discovered that Alexe's tumour was too large to be removed through the nasal cavity, leading to a gruelling 16-hour operation. A mere 24 hours later, she was rushed back into surgery due to complications from a brain bleed, necessitating the removal of a blood clot. Alexe was then put into a medically induced coma and spent the following six months in hospital. When Alexe finally regained consciousness, she had lost her ability to speak, walk or feel the right side of her body. Alexe recalled: 'I was confused and suffering severe memory loss, I thought the hospital was home. I had to re-live the devastating news that my dad had died, I didn't even recognise my own brother or best friend.' Following months of physiotherapy and speech therapy, during which she initially communicated by pointing at pictures, Alexe was diagnosed with a neurocytoma of the pituitary gland. She remained in hospital for nearly a year. In 2007, an MRI scan revealed that Alexe's tumour had regrown. She expressed: 'Hearing the tumour had come back filled me with dread and fear. It absolutely broke my heart. I thought I couldn't go through it all again.' Alexe underwent a week of intensive radiotherapy at Whitchurch Community Hospital in Wales. Despite being told that she would be unable to conceive due to the radiotherapy, Alexe and her husband Dean explored intrauterine insemination (IUI), but were unsuccessful. The couple decided to become foster parents instead, a choice that has transformed numerous lives. Over the years, they have fostered 29 children, including Mikey, who chose to remain part of their family permanently. Alexe's initial round of IVF was successful, resulting in the birth of her daughter, Amelia, who is now 12 years old. Alexe said: 'I was so thrilled, relieved, and shocked. After everything I'd been through, and after being told I couldn't have children, it felt like a miracle.' In 2014, three years later, Alexe started feeling unwell again. Bracing herself for news of another recurrence, she was instead informed that she was naturally pregnant - a possibility doctors had previously ruled out. Alexe said: 'We were so thrilled, relieved and shocked. After being told I'd never have children, to find out I was pregnant naturally, I couldn't believe it. It was amazing news.' Today, Alexe and Dean live a happy life with their daughters Amelia and Georgia-Mae, aged 12 and nine respectively. Despite living with delayed speech, Alexe has regained full mobility and continues to undergo routine six-monthly scans. She keeps active by participating in weekly park runs and uses her experience to raise awareness about brain tumours. Alexe stated: 'My life fell apart overnight. Brain tumours aren't always the end. There is hope and there is life after a brain tumour. I have focussed on my health and lost five stone, I'm living proof. But in order to have more survivors, research into brain tumours needs more funding and more research.' According to the charity Brain Tumour Research, brain tumours are the leading cause of death in children and adults under the age of 40, more than any other cancer. The charity supports sustainable research at dedicated centres across the UK, and is spearheading the call for an annual national spend of £35 million to enhance survival rates and patient outcomes, aligning with other cancers such as breast cancer and leukaemia. A mere 1% of the national expenditure on cancer research has been dedicated to this devastating disease. Letty Greenfield, Community Development Manager at Brain Tumour Research, said: 'Alexe's story is a powerful reminder of the resilience of the human spirit and the urgent need for more research into brain tumours. "Her journey shows that even in the face of devastating diagnoses, there can be hope, recovery and life beyond a brain tumour. Stories like Alexe's inspire our work every day and highlight why we must continue to campaign for greater investment in research to improve outcomes for patients."
